Cargando…
Baicalin Prevents Myocardial Ischemia/Reperfusion Injury Through Inhibiting ACSL4 Mediated Ferroptosis
Baicalin is a natural flavonoid glycoside that confers protection against myocardial ischemia/reperfusion (I/R) injury. However, its mechanism has not been fully understood. This study focused on elucidating the role of ferroptosis in baicalin-generated protective effects on myocardial ischemia/repe...
Autores principales: | Fan, Zhenyu, Cai, Liangliang, Wang, Shengnan, Wang, Jing, Chen, Bohua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8079950/ https://www.ncbi.nlm.nih.gov/pubmed/33935719 http://dx.doi.org/10.3389/fphar.2021.628988 |
Ejemplares similares
-
HJ11 decoction restrains development of myocardial ischemia-reperfusion injury in rats by suppressing ACSL4-mediated ferroptosis
por: Zhang, Fangyuan, et al.
Publicado: (2022) -
Dexmedetomidine Attenuates Ferroptosis-Mediated Renal Ischemia/Reperfusion Injury and Inflammation by Inhibiting ACSL4 via α2-AR
por: Tao, Wen-hui, et al.
Publicado: (2022) -
Baicalin Inhibits Ferroptosis in Intracerebral Hemorrhage
por: Duan, Lining, et al.
Publicado: (2021) -
Dapagliflozin alleviates myocardial ischemia/reperfusion injury by reducing ferroptosis via MAPK signaling inhibition
por: Chen, Weixiang, et al.
Publicado: (2023) -
Ischemia-induced ACSL4 activation contributes to ferroptosis-mediated tissue injury in intestinal ischemia/reperfusion
por: Li, Yang, et al.
Publicado: (2019)